alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 1 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 2 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 3 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 4 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 5 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 6 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 7 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 8 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 9 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 10 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 11 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 12 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 13 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 14 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 15 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 16 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 17 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 18 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 19 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 20 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 21 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 22 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 23 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 24 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 25 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 26 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 27 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 28 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 29 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 30 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 31 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 32 of 33
Case 1:07-cv-05804-GEL Document 18-4 Filed 05/02/2008 Page 33 of 33
Case 1:07-cv-04462-AKH Document 13-2 Filed 08/23/2007 Page 1 of 2
Case 1:07-cv-04462-AKH Document 13-2 Filed 08/23/2007 Page 2 of 2
CX and

CX Clearinghouse

499 Park Avenue 

New York, NY 10022

+1 877-300-4555

info@cantorexchange.com

www.cantorexchange.com

CX is a registered trademark of CX Futures Exchange, L.P. or its affiliates in the U.S. and/or other countries.

June 11, 2020

By Electronic Submission via CFTC Portal

Assistant Secretary of the CFTC 

for FOIA Matters 

Three Lafayette Centre

1155 21st Street, NW

Washington, DC 20581

Re: Freedom of Information Act Confidential Treatment Request for:

Confidential Attachment A to Submission 2020-03 CX Compliance 

Manual Addendum

Dear Sir or Madam:

CX Futures Exchange L.P. (the “Requestor”) hereby requests that the 

document referenced above and enclosed herewith be afforded confidential 

treatment in accordance with the Freedom of Information Act (“FOIA”), 5 USC 

552 and CFTC rules thereunder, 17 C.F.R. 145.9, for an indefinite period of time 

due to the sensitive commercial and proprietary nature of such information, 

public disclosure of which could be detrimental to the Requestor. As prescribed 

by 17 C.F.R. 145.9(d)(4), each page of the documents included in this request 

bear the legend “Confidential Treatment Requested by CX Futures Exchange, 

L.P.”

In accordance with the foregoing regulations, kindly notify me at 

nglantz@cantorexchange.com or 212-610-3645 of any request under FOIA for 

access to the enclosed documents to enable the Requestor to substantiate the 

grounds for confidential treatment, or if you have any questions regarding this 

document.

Thank you very much for your consideration.

Sincerely,

Nolan Glantz

Chief Operations Officer

CX Futures Exchange, L.P.

Enclosure: CX Compliance Manual Addendum 40.6 2020-06-10.pdf
# C_2018094EN.01002402.xml

| 12.3.2018 | EN | Official Journal of the European Union | C 94/24 |
| --- | --- | --- | --- |

12.3.2018

EN

Official Journal of the European Union

C 94/24

---

Judgment of the General Court of 24 January 2018 — Constantin Film Produktion v EUIPO (Fack Ju Göhte)

(Case T-69/17) (1)

1

((EU trade mark - Application for the EU word mark Fack Ju Göhte - Absolute ground for refusal - Trade mark contrary to public policy or to accepted principles of morality - Article 7(1)(f) of Regulation (EC) No 207/2009 (now Article 7(1)(f) of Regulation (EU) 2017/1001)))

(2018/C 094/32)

Language of the case: German

Parties

Parties

Applicant: Constantin Film Produktion GmbH (Munich, Germany) (represented by: E. Saarmann and P. Baronikians, lawyers)

Applicant:

Defendant: European Union Intellectual Property Office (represented by: M. Fischer and D. Walicka, acting as Agents)

Defendant:

Re:

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 1 December 2016 (Case R 2205/2015–5), concerning an application for registration of the word sign Fack Ju Göhte as an EU trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Constantin Film Produktion GmbH to pay the costs. |
| --- | --- |

2.

Orders Constantin Film Produktion GmbH to pay the costs.

---

(1)  OJ C 104, 3.4.2017.

1

---
(83 South. 927)

#### McCreary v. Stallworth et al.

(1 Div. 105.)

(Supreme Court of Alabama.

Nov. 11, 1919.)

Appeal from Circuit Court, Monroe County; Ben D. Turner, Judge.

A. C. Lee, of Monroeville, for appellees.

PER CURIAM.

Appeal dismissed for want of prosecution.
[Federal Register Volume 66, Number 96 (Thursday, May 17, 2001)]
[Notices]
[Page 27490]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-12414]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Forest Service


Southwest Oregon Province Interagency Executive Committee (PIEC) 
Advisory Committee

AGENCY: Forest Service, USDA.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Southwest Oregon PIEC Advisory Committee will meet on June 
5, 2001 in Medford, Oregon at the Medford Bureau of Land Management 
Office at 3040 Biddle Road. The meeting will begin at 9 a.m. and 
continue until 5 p.m. Agenda items to be covered include: (1) Province 
Advisory Committee Operating Guidelines; (2) Public Comment; (3) 
Discussion of Land Management Issues; and (4) Current issues as 
perceived by Advisory Committee members.

FOR FURTHER INFORMATION CONTACT: Direct questions regarding this 
meeting to Roger Evenson, Province Advisory Committee Coordinator, 
USDA, Forest Service, Umpqua National Forest, 2900 NW Stewart Parkway, 
Roseburg, Oregon 97470, phone (541) 957-3344.

    Dated: May 11, 2001.
Michael D. Hupp,
Acting Designated Federal Official.
[FR Doc. 01-12414 Filed 5-16-01; 8:45 am]
BILLING CODE 3410-11-M
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1819 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
116th CONGRESS
  2d Session
                                H. R. 1819

_______________________________________________________________________

                                 AN ACT

 
To amend the State Department Basic Authorities Act of 1956 to provide 
 for rewards for the arrest or conviction of certain foreign nationals 
   who have committed genocide or war crimes, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``War Crimes Rewards Expansion Act''.

SEC. 2. DEPARTMENT OF STATE REWARDS PROGRAM.

    Paragraph (10) of section 36(b) of the State Department Basic 
Authorities Act of 1956 (22 U.S.C. 2708(b)) is amended by striking 
``defined under the statute of such tribunal;'' and inserting the 
following: ``defined under--
                    ``(A) the statute of such country or tribunal, as 
                the case may be; or
                    ``(B) United States law;''.

            Passed the House of Representatives December 3, 2020.

            Attest:

                                                                 Clerk.
116th CONGRESS

  2d Session

                               H. R. 1819

_______________________________________________________________________

                                 AN ACT

To amend the State Department Basic Authorities Act of 1956 to provide 
 for rewards for the arrest or conviction of certain foreign nationals 
   who have committed genocide or war crimes, and for other purposes.
```
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported):   April 28, 2004

|CNS, INC.                                              | 
|------------------------------------------------------ | 
|                                                       | 
|(Exact name of Registrant as specified in its charter) | 
|                                                      
|Delaware                                               | 
|                                                       | 
|(State or other jurisdiction of incorporation)         | 
|                                                      
|7615 Smetana LaneEden Prairie, MN                      | 
|                                                       | 
|(Address of principal executive offices)               | 
|                                                      
|                                                      
|Registrants telephone number, including area code     | 

---

Items 1-4, 6 and 8-11 are not applicable and therefore omitted.

# ITEM 5.   OTHER EVENTS.

On April 28, 2004, CNS, Inc. (the Company) issued a press release, attached hereto as Exhibit 99.1, announcing a
five cent per share quarterly dividend payable June 4, 2004 to shareholders of record as of May 21, 2004.

# ITEM 7.   FINANCIAL STATEMENTS AND EXHIBITS.

| | (c) |  | Exhibits
| | --- |  | --------

| | The following is filed as an Exhibit to this Report:
| | ----------------------------------------------------

| | Exhibit No. |  | Description of Exhibit              
| | ----------- |  | ------------------------------------
| | 99.1        |  | Press release issued April 28, 2004.
| |            

| | The following is furnished as an Exhibit to this Report:
| | --------------------------------------------------------

| | Exhibit No. |  | Description of Exhibit              
| | ----------- |  | ------------------------------------
| | 99.2        |  | Press release issued April 29, 2004.

# ITEM 12.   DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

Pursuant to Item 12 of Form 8-K,
Disclosure of Results of Operations and Financial Condition, CNS, Inc. hereby furnishes a
press release, issued on April 29, 2004, disclosing material non-public information
regarding its results of operations for the year and quarter ended March 31, 2004.

# SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| |                                                    |           |  |                     | 
| | -------------------------------------------------- | --------- |  | ------------------- | 
| |                                                    | CNS, INC.
| |                                                    | By:       |  | /s/   Marti Morfitt | 
| |                                                   
| | Marti MorfittPresident and Chief Executive Officer |          

Dated: April 29, 2004

---
Letter to Joseph M. Zubretsky dated December 21, 2005



 Exhibit 10.2 
  

	
	 SUSAN N. ROTH
 VICE PRESIDENT, CORPORATE SECRETARY
 AND ASSISTANT GENERAL COUNSEL
 LAW DEPARTMENT
 TEL: 423.294.8913   FAX:
423.294.2590



  
 December 21, 2005 
  
 Joseph M.
Zubretsky 
 Louise Terrace Apartments # 309 
 316 Walnut Street 
 Chattanooga, TN 37402 
  
 Re: Employment Agreement dated March 1,
2005 between Joseph M. Zubrestky (“Employment Agreement”) and UnumProvident Corporation 
  
 Dear Joe: 
  
 This letter is to notify you of and confirm changes in the calculation of certain benefits under the Employment Agreement. Paragraph 8(a) of the Employment Agreement
states: 
  
 “(i) the Company shall pay to Executive in a
lump sum in cash within 30 days after the Date of Termination the aggregate of the following amounts: 
  

	 	A.	the sum of (1) Executive’s Base Salary through the Date of Termination to the extent not theretofore paid, and (2) the product of (x) the highest annual bonus
paid to Executive for any three years prior to the Date of Termination or, if the CEO’s Employment Agreement with the Company is hereafter amended to so provide, the average of the annual bonuses paid to Executive for the three years prior to
the Date of Termination (the “Applicable Bonus”) and (y) the fraction, the numerator of which is the number of days in the current fiscal year through the Date of Termination, and the denominator of which is 365 (the sum of the
amounts described in clauses (1) and (2) shall hereinafter be referred to as the “Accrued Obligations”); and ... 

  
 (v) if the Date of Termination occurs during the CIC Period, the Company shall pay to Executive a lump sum cash payment equal to the difference between
(A) the actuarial present value of the Retirement Benefit determined using the actuarial assumptions prescribed under the tax-qualified defined benefit plan under which the Executive was eligible for participation at the Date of Termination,
assuming Executive had accumulated three (3) additional years of 







 employment (and if the CEO’s Employment Agreement with the Company is hereafter amended to so
provide, three (3) additional years of attained age), and (B) the actuarial present value of the Retirement Benefit determined using the actuarial assumptions prescribed under the tax-qualified defined benefit plan under which Executive
was eligible for participation at the Date of termination; and...” 
  
 Effective December 16, 2005, the CEO’s Employment Agreement referred to in your Employment Agreement was amended to change the severance payment formula to include a calculation based on the average of Mr. Watjen’s prior
three years’ annual bonuses rather than his highest annual bonus paid in the prior three years, and to change the calculation of the retirement benefit portion of the severance payment to include credit for an additional three years of age as
well as service. Therefore, calculations under the respective provisions of Paragraph 8(a)(1)(A) and 8(a)(v) effective December 16, 2005 will reflect these amendments. 
  
 Please contact me if you have any questions. 
  
 Sincerely, 
  
 /s/ Susan N. Roth 

 Susan N. Roth
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the
incorporation by reference in the Registration Statement on Form S-8 (No. 333-98203) of Hennessy Advisors, Inc. of our report dated December 3, 2009, with respect to the financial statements of Hennessy Advisors, Inc. for each of the two years
ended September 30, 2008 and September 30, 2009, included in the annual report (Form 10-K) for the year ended September 30, 2009.



|                              
|------------------------------
|/s/ Stonefield Josephson, Inc.
|                              
|Stonefield Josephson, Inc.    
|San Francisco, California     
|December 3, 2009
Fourth Court of Appeals

San Antonio, Texas

April 13, 2020

No. 04-20-00178-CV

IN RE PROGRESSIVE COUNTY MUTUAL INSURANCE COMPANY

From the 166th Judicial District Court, Bexar County, Texas

Trial Court No. 2019CI21744

Honorable John D. Gabriel, Jr., Judge Presiding

O R D E R

Sitting: Rebeca C. Martinez, Justice

Patricia O. Alvarez, Justice

Liza A. Rodriguez, Justice

The Unopposed Motion for Extension of Time to File Real Party in Interest’s Response 

to Petition for Writ of Mandamus is hereby GRANTED. Time is extended until May 5, 2020.

It is so ORDERED on April 13, 2020.

 PER CURIAM

ATTESTED TO: ______________________

 MICHAEL A. CRUZ,

 CLERK OF COURT
June 9, 2006

VIA ELECTRONIC AND OVERNIGHT MAIL
Eileen Donovan

Assistant Secretary

to the Commission for FOIA Matters

Co compliance fee UMFIDENTIAL TREATMENT

Commodity Futures Trading Commission
3 Lafayette Centre REQUESTER
1155 21st Street, NW

Washington, D.C. 20581

Re: FOIA Confidential Treatment Request

Dear Ms. Donovan:

By electronic transmission dated today, June 9, 2006, the New York Mercantile Exchange, Inc.
(“NYMEX’ or the “Exchange”) submitted a self-certification rule filing to the Commodity Futures Trading
Commission (NYMEX Submission No. 06-73). The filing pertains to certain sections of a technology
services agreement between NYMEX and the Chicago Mercantile Exchange (“CME”).

Pursuant to Sections 8 and 8(a) of the Commodity Exchange Act, as amended, (“CEA”) and
Commission Regulation 145.9(d), NYMEX requests confidential treatment of the entire agreement
including all exhibits to the agreement (collectively “the Agreement”) and this letter on the grounds that
disclosure of the Agreement would reveal confidential trade secrets and commercial and financial
information of NYMEX as well as of the CME. Pursuant to Commission Regulation 145.9(d)(5), NYMEX
requests that confidential treatment be maintained for the Agreement until further notice from the
Exchange. We also request that the Commission notify the undersigned immediately after receiving any
FOIA request for said Agreement or any other court order, subpoena or summons for same. Finally, we
request that we be notified in the event the Commission intends to disclose such Agreement to Congress
or to any other governmental agency or unit pursuant to Section 8 of the CEA. NYMEX does not waive its
notification rights under Section 8(f) of the CEA with respect to any subpoena or summons for such
Agreement


Eileen Donovan
June 9, 2006
Page 2

Please contact the undersigned at (212) 299-2207 should you have any questions concerning this

letter.

Very truly yours,

Brian J. Regan
Vice President and Counsel

Enclosure
Exhibit 10.34
  INVERNESS MEDICAL INNOVATIONS PLC (the Company)
 HM REVENUE AND CUSTOMS SHARE OPTION PLAN (2007) (the Plan)
    Proportion of Shares over whichthe Option may be exercised from
    
    Cumulative proportion of the SharesSpecified Anniversary
    
    the Specified Anniversary
    
    which the Option may be exercised1st anniversary of the
Date of Grant
    
    One quarter of the Shares subject to
the Option, rounded up if necessary to
nearest whole Share.
    
    One quarter of the Shares subject to the
Option, rounded up if necessary to
nearest whole Share2nd anniversary of the
Date of Grant
    
    One quarter of the Shares subject to
the Option, rounded up if necessary to
nearest whole Share.
    
    Half of the Shares subject to the Option,
rounded up if necessary to nearest whole
Share.3rd anniversary of the Date of Grant
    
    One quarter of the Shares subject to
the Option, rounded up if necessary to
nearest whole Share.
    
    Three quarters of the Shares subject to
the Option, rounded up if necessary to nearest whole Share.4th anniversary of the Date of Grant
    
    The Shares subject to the Option over
which the Option has not before that
date become exerciseable.
    
    All of the Shares subject to the Option.
 In accordance with Rule 6.8 of the Plan, the Grantor has determined that it shall NOT be a
condition of exercise of this Option for you to be responsible for paying any employers national
insurance contributions arising as a result of the exercise of this Option.
  SIGNEDas a deed by
    
    )INVERNESS MEDICAL INNOVATIONS INC
    
    )acting by
    
    )David Teitel, Treasurer
 Notes:
 1.
    
    The Option is not assignable but may be exercised by your estate in the event of your death.2.
    
    A Participant may, by notice in writing to the Company given within 30 days after the Date of
Grant, renounce in whole or in part his rights under the Option.
 1




---



##### 



INVERNESS MEDICAL INNOVATIONS INC
 HM REVENUE AND CUSTOMS SHARE OPTION PLAN (2007) (the Plan)
 Notice of Exercise of an Option
  (insert number)
 
 Name (Block capitals):Address:Signature:
    
    Date:
 Notes:
 1.
    
    Where the Option is exercised by personal representatives, an office copy of the Probate or
Letters of Administration should accompany this form.2.
    
    IMPORTANT: If your Option is exercised within three years of the date of grant, (otherwise
than as a result of injury, disability, redundancy or retirement in circumstances where such
exercise occurs within 6 months of the day on which you cease to be an employee of a
Participating Company) you will be liable to income tax on any gain which arises on exercise
and you should complete Notice of Exercise (2) instead. Your personal representative will not
be subject to any income tax should they exercise your Option following your death. If you are
unsure of the tax liabilities that may arise, you should take appropriate professional advice
before exercising your Option.
 2